MoneyWorks4Me

IOL Chemicals and Pharmaceuticals reports 11% fall in Q3 consolidated net profit

13 Feb 2025 Evaluate

IOL Chemicals and Pharmaceuticals has reported results for third quarter ended December 31, 2024 (Q3FY25). 

The company has reported 11.54% decline in its net profit at Rs 20.55 crore for Q3FY25 as compared to  net profit of Rs 23.23 crore for the same quarter in the previous year. Total income of the company decreased marginally at Rs 527.37 crore for Q3FY25 as compared to Rs 528.77 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 11.05% decline in its net profit at Rs 20.53 crore for the quarter ended December 31, 2024 as compared to  net profit of Rs 23.08 crore for the same quarter in the previous year. Total income of the company decreased marginally at Rs 527.37 crore for Q3FY25 as compared to Rs 528.77 crore for the corresponding quarter previous year.


Peers
Company Name CMP
Sun Pharma. Inds. 1844.15
Dr. Reddys Labs. 1142.55
Cipla 1370.80
Lupin 2077.80
Zydus Lifesciences 1112.95
View more..